Please assess the completion status of the following clinical trial:

Trial Title: Physiopathologic Study of Induced by Thoracotomy / Thoracoscopy Neuropathy Mechanism

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria :~* patients undergoing lateral or posterolateral thoracotomy scheduled lung surgery, regardless of indication, or lung or pleural scheduled surgery (treatment of recurrent pneumothorax) by thoracoscopy;~* 18 to 80 years~* Informed consent to the trial~* Protected by the French health welfare~Exclusion Criteria:~* Refusal of the patient;~* Preexisting neuropathy ;~* Treatment of active substance known on neuropathic pain: gabapentin, pregabalin, amitryptyline, duloxetine, venlafaxine, tricyclic antidepressants, topical lidocaine or capsaicin;~* Emergency surgery;~* Specific clinical contexts including terminal or palliative neoplasia;~* Deficit psychiatric pathology and dementia.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- neuropathic pain (Type: None): This study will be proposed to patients undergoing thoracotomy or thoracoscopy for partial or total lung resection in the service of Thoracic Surgery of Centre Jean Perrin (Prof. M. Filaire), the objective is to recruit 120 patients (for 100 evaluable patients) over a period of 18 months of inclusion

Based on this trial design, predict the completion outcome and termination type (if applicable).